Neogen Chemicals Ltd (NEOGEN) Q2FY25 Concall Summary - Sep-2024 Qtr
Performance Overview
- Neogen Chemicals demonstrated robust performance in Q2 FY25 despite a challenging market environment marked by weak demand, oversupply, geopolitical tensions, and inflation.
- Volume gains in the base business, along with contributions from BuLi Chemicals and Neogen Ionics, drove the company's performance.
- Revenue grew by 20% YoY to Rs. 193 crore, EBITDA increased by 33% YoY to Rs. 35 crore, and profit after tax rose by 38% YoY to Rs. 11 crore.
- Organic chemicals revenue grew by 34% YoY, while inorganic chemicals revenue declined by 24% YoY due to lower lithium prices.
- The company is well-positioned to capitalize on India's expanding EV market and the increasing demand for locally sourced electrolytes.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.